Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study

OBJECTIVE: This open, randomized and blinded parallel-group multicenter study evaluated the efficacy of Actonel(r) (35 mg) plus calcium/vitamin D versus calcium/vitamin D alone for preserving bone mineral density (BMD) in postmenopausal women with Colles fractures.METHODS: Patients with a Colles fra...

Full description

Bibliographic Details
Main Authors: Lindomar Guimarães Oliveira, Sérgio Ragi Eis, Henrique Mota Neto, Frederico Barra de Moraes, Luiz Antônio Silveira Simões Pires, José Wanderley Vasconcelos
Format: Article
Language:English
Published: Sociedade Brasileira de Ortopedia e Traumatologia 2015-06-01
Series:Revista Brasileira de Ortopedia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-36162015000300274&lng=en&tlng=en
_version_ 1797329533199712256
author Lindomar Guimarães Oliveira
Sérgio Ragi Eis
Henrique Mota Neto
Frederico Barra de Moraes
Luiz Antônio Silveira Simões Pires
José Wanderley Vasconcelos
author_facet Lindomar Guimarães Oliveira
Sérgio Ragi Eis
Henrique Mota Neto
Frederico Barra de Moraes
Luiz Antônio Silveira Simões Pires
José Wanderley Vasconcelos
author_sort Lindomar Guimarães Oliveira
collection DOAJ
description OBJECTIVE: This open, randomized and blinded parallel-group multicenter study evaluated the efficacy of Actonel(r) (35 mg) plus calcium/vitamin D versus calcium/vitamin D alone for preserving bone mineral density (BMD) in postmenopausal women with Colles fractures.METHODS: Patients with a Colles fracture for seven days were randomized to receive either Actonel(r) (35 mg) once a week plus calcium/vitamin D (ACD group) or calcium/vitamin D alone (CD group). The patients were evaluated after 90 and 180 days of treatment.RESULTS: 59 ACD patients and 56 CD patients completed all the evaluations. At the end of the study, the BMD of the radius at the fracture location showed a negative change in the CD group (32.8%). The loss of BMD in the ACD group (20.8%) was slightly less than that in the CD group. There was a difference in the proportions of patients with BMD losses at the end of the study period in the two treatment groups, in favor of the ACD group, although this was not statistically significant. There was no significant difference in radiological identification of callus formation between the treatment groups. In the majority of the patients, the callus could be radiologically identified after 90 days.CONCLUSION: Postmenopausal women with Colles fractures who received risedronate sodium plus calcium/vitamin D did not show any significant difference in BMD loss in forearm fractures, in comparison with those who received calcium/vitamin D alone. Risedronate presented a tendency toward a protective effect regarding BMD loss due to immobilization. The time taken for fracture consolidation to be achieved was unaffected.
first_indexed 2024-03-08T07:06:39Z
format Article
id doaj.art-5b5c062467914f87b258d823734d7318
institution Directory Open Access Journal
issn 1982-4378
language English
last_indexed 2024-03-08T07:06:39Z
publishDate 2015-06-01
publisher Sociedade Brasileira de Ortopedia e Traumatologia
record_format Article
series Revista Brasileira de Ortopedia
spelling doaj.art-5b5c062467914f87b258d823734d73182024-02-03T04:23:53ZengSociedade Brasileira de Ortopedia e TraumatologiaRevista Brasileira de Ortopedia1982-43782015-06-0150327428210.1016/j.rboe.2015.04.004S0102-36162015000300274Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID studyLindomar Guimarães OliveiraSérgio Ragi EisHenrique Mota NetoFrederico Barra de MoraesLuiz Antônio Silveira Simões PiresJosé Wanderley VasconcelosOBJECTIVE: This open, randomized and blinded parallel-group multicenter study evaluated the efficacy of Actonel(r) (35 mg) plus calcium/vitamin D versus calcium/vitamin D alone for preserving bone mineral density (BMD) in postmenopausal women with Colles fractures.METHODS: Patients with a Colles fracture for seven days were randomized to receive either Actonel(r) (35 mg) once a week plus calcium/vitamin D (ACD group) or calcium/vitamin D alone (CD group). The patients were evaluated after 90 and 180 days of treatment.RESULTS: 59 ACD patients and 56 CD patients completed all the evaluations. At the end of the study, the BMD of the radius at the fracture location showed a negative change in the CD group (32.8%). The loss of BMD in the ACD group (20.8%) was slightly less than that in the CD group. There was a difference in the proportions of patients with BMD losses at the end of the study period in the two treatment groups, in favor of the ACD group, although this was not statistically significant. There was no significant difference in radiological identification of callus formation between the treatment groups. In the majority of the patients, the callus could be radiologically identified after 90 days.CONCLUSION: Postmenopausal women with Colles fractures who received risedronate sodium plus calcium/vitamin D did not show any significant difference in BMD loss in forearm fractures, in comparison with those who received calcium/vitamin D alone. Risedronate presented a tendency toward a protective effect regarding BMD loss due to immobilization. The time taken for fracture consolidation to be achieved was unaffected.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-36162015000300274&lng=en&tlng=enConsolidação da fraturaFratura de CollesDifosfonatos
spellingShingle Lindomar Guimarães Oliveira
Sérgio Ragi Eis
Henrique Mota Neto
Frederico Barra de Moraes
Luiz Antônio Silveira Simões Pires
José Wanderley Vasconcelos
Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
Revista Brasileira de Ortopedia
Consolidação da fratura
Fratura de Colles
Difosfonatos
title Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
title_full Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
title_fullStr Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
title_full_unstemmed Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
title_short Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
title_sort use of risedronate for consolidation and callus formation in colles fractures in postmenopausal women solid study
topic Consolidação da fratura
Fratura de Colles
Difosfonatos
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-36162015000300274&lng=en&tlng=en
work_keys_str_mv AT lindomarguimaraesoliveira useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy
AT sergioragieis useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy
AT henriquemotaneto useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy
AT fredericobarrademoraes useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy
AT luizantoniosilveirasimoespires useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy
AT josewanderleyvasconcelos useofrisedronateforconsolidationandcallusformationincollesfracturesinpostmenopausalwomensolidstudy